-
The Centers for Medicare and Medicaid Services is creating an infection control inspection survey for hospitals as part of its participation in the recently formed Partnership for Patients.
-
There has been so much hoopla about driving central line-associated bloodstream infections (CLABSIs) down to zero with checklists and bundles, that a unit that fails to achieve such success may take it somewhat personal.
-
UTIs have been termed the Rodney Dangerfield of infections, out of a skewed perception that they are easy to treat and have relatively little clinical consequence.
-
In May of this year, German public health authorities reported a significant increase in the number of patients with diarrhea caused by a Shiga toxin-producing Escherichia coli (STEC), as well as of cases of hemolytic uremic syndrome (HUS).
-
The number of individuals with active tuberculosis in the United States reached an all-time low of 11,181 cases in 2010.
-
The National Health Service in Britain in 2007 elected to ban traditional white coats and other long-sleeved garments for physicians in the workplace (including long-sleeved blouses and shirts).
-
In this issue: Two new drugs for treatment of hepatitis C; NSAIDs and myocardial infarction risk; AIM-HIGH clinical trial stopped; and FDA actions.
-
-
A 52-year-old woman had systemic symptoms including nausea and vomiting. Seven months prior to admission she had a subarachnoid hemorrhage and needed multiple ventriculo-pleural shunts.
-
Raltegravir (RAL) received FDA approval in 2007 and is now used in treatment of both treatment-experienced and treatment-naïve patients.
